John Ho, MD
Vascular & Interventional Radiology · Lewiston, IDNPI 1023096955
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 33.9% of the total. 2025 is the largest year on record at $3,035, 2.8 times the $1,091 reported in 2019.
Across 202 payments — averaging $49.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$3K
- Medtronic$2K
- Silk Road Medical, Inc.$1K
- Microvention, Inc.$608
- Endologix LLC$511
- Boston Scientific$318
- plus $2K from 24 others
What the payments were for
- Consulting fees$7888%
- Travel & lodging$3,52935%
- Food & beverage$5,74457%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 83 | $3,409 |
| Medtronic(2 entities) | 23 | $2,235 |
| Silk Road Medical, Inc. | 15 | $1,082 |
| Microvention, Inc. | 4 | $608 |
| Endologix LLC | 2 | $511 |
| Boston Scientific | 13 | $318 |
| Shockwave Medical, Inc | 9 | $263 |
| Stryker | 3 | $257 |
| Johnson & Johnson | 10 | $243 |
| Inari Medical, Inc. | 3 | $194 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 3 | $123 |
| Siemens Medical Solutions USA, Inc. | 1 | $87 |
| Abbott | 3 | $72 |
| Penumbra, Inc. | 3 | $70 |
| GE HealthCare | 2 | $67 |
| Pfizer | 4 | $62 |
| Globus Medical | 2 | $61 |
| Bard Peripheral Vascular, Inc. | 2 | $55 |
| Philips North America LLC | 3 | $53 |
| Inspiremd Ltd | 1 | $49 |
| Nevro Corp. | 2 | $43 |
| Imperative Care, Inc | 2 | $40 |
| Terumo Medical Corporation | 2 | $34 |
| Sirtex Medical Inc | 1 | $25 |
| Boehringer Ingelheim | 1 | $21 |
| BD | 1 | $20 |
| Surmodics, Inc. | 1 | $20 |
| Cook Medical LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $12 |
| Lemaitre Vascular, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$1,225
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,224
- RIST$1,117
- ENROUTE Transcarotid Stent$788
- VenaSeal$513
- Torus Stent Graft System$511
- ENDOCROSS Device$511
- WEB$510
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$438
- ARTIX MT$231
- FLOWTRIEVER CATHETER, S$136
- CT THROMBECTOMY SYSTEM KIT$136
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$113
How this compares
Too few vascular & interventional radiology providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 171 | $177,048 |
| ClopidogrelClopidogrel Bisulfate | 564 | $6,732 |
| Pregabalin | 103 | $2,971 |
| Cilostazol | 89 | $2,120 |
| Enoxaparin Sodium | 18 | $1,613 |
| Gabapentin | 72 | $787 |
| Potassium Chloride | 34 | $624 |
| Nifedipine ErNifedipine | 26 | $476 |
| Amlodipine Besylate | 63 | $413 |
| Spironolactone | 38 | $383 |
| Losartan Potassium | 18 | $316 |
| Pantoprazole Sodium | 25 | $290 |
| Atorvastatin Calcium | 16 | $256 |
| Furosemide | 50 | $246 |
| Amitriptyline Hcl | 16 | $235 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $62 | $177,048171 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few vascular & interventional radiology providers in Idahoon file to place this against a meaningful peer group, so we don't.
Other vascular & interventional radiology in Lewiston
- Mark PetersonLewiston$195
- David ShelleyBlackfoot$37K
- Daniel GibsonBoise$35K
- Derek KhorsandCoeur D Alene$10K
- Whitney Shofner MichalskyBoise$9K
- David CondieBlackfoot$6K
- John WhitingPocatello$5K
- Sean CarrBoise$5K
- Jared BaileyPocatello$3K
- Andrew PetersonBoise$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.